| Mr James Michael Orcutt, MD | |
|
2085 Henry Tecklenburg Dr Fl 2, Charleston, SC 29414-7710 | |
| (843) 577-6957 | |
| Not Available |
| Full Name | Mr James Michael Orcutt |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 34 Years |
| Location | 2085 Henry Tecklenburg Dr Fl 2, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336107424 | NPI | - | NPPES |
| P00365927 | Other | SC | RAILROAD MEDICARE |
| T27815 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 18866 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours-st Francis Xavier Hospital | Charleston, SC | Hospital |
| Roper Hospital | Charleston, SC | Hospital |
| Mount Pleasant Hospital | Mount pleasant, SC | Hospital |
| Roper St Francis Hospital-berkely Inc | Moncks corner, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours St Francis Xavier Hospital Inc | 8325008717 | 164 |
News Archive
On Capitol Hill this week, the health law's independent payment advisory panel drew criticism from both Democrats and Republicans. Health and Human Services Secretary Kathleen Sebelius was on hand to absorb some of the attacks and answer some of the questions.
Researchers have made a drug that helps the immune system to break down cancerous tumors. It has worked on breast, bowel, prostate, ovarian, brain, bladder and liver cancers, while previous studies show it can also be used to fight some blood cancers. If given early, the drug could even be a cure, researchers say.
Esteya, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration, enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.
A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers at Penn State College of Medicine.
› Verified 4 days ago
| Entity Name | Bon Secours St Francis Xavier Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770867442 PECOS PAC ID: 8325008717 Enrollment ID: O20041011000439 |
News Archive
On Capitol Hill this week, the health law's independent payment advisory panel drew criticism from both Democrats and Republicans. Health and Human Services Secretary Kathleen Sebelius was on hand to absorb some of the attacks and answer some of the questions.
Researchers have made a drug that helps the immune system to break down cancerous tumors. It has worked on breast, bowel, prostate, ovarian, brain, bladder and liver cancers, while previous studies show it can also be used to fight some blood cancers. If given early, the drug could even be a cure, researchers say.
Esteya, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration, enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.
A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers at Penn State College of Medicine.
› Verified 4 days ago
| Entity Name | Charleston Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427140425 PECOS PAC ID: 3173521002 Enrollment ID: O20061201000038 |
News Archive
On Capitol Hill this week, the health law's independent payment advisory panel drew criticism from both Democrats and Republicans. Health and Human Services Secretary Kathleen Sebelius was on hand to absorb some of the attacks and answer some of the questions.
Researchers have made a drug that helps the immune system to break down cancerous tumors. It has worked on breast, bowel, prostate, ovarian, brain, bladder and liver cancers, while previous studies show it can also be used to fight some blood cancers. If given early, the drug could even be a cure, researchers say.
Esteya, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration, enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.
A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers at Penn State College of Medicine.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Michael Orcutt, MD Po Box 751874, Charlotte, NC 28275-1874 Ph: (843) 402-5200 | Mr James Michael Orcutt, MD 2085 Henry Tecklenburg Dr Fl 2, Charleston, SC 29414-7710 Ph: (843) 577-6957 |
News Archive
On Capitol Hill this week, the health law's independent payment advisory panel drew criticism from both Democrats and Republicans. Health and Human Services Secretary Kathleen Sebelius was on hand to absorb some of the attacks and answer some of the questions.
Researchers have made a drug that helps the immune system to break down cancerous tumors. It has worked on breast, bowel, prostate, ovarian, brain, bladder and liver cancers, while previous studies show it can also be used to fight some blood cancers. If given early, the drug could even be a cure, researchers say.
Esteya, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration, enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.
A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers at Penn State College of Medicine.
› Verified 4 days ago
Dr. Jeffrey Peter Yourshaw, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-876-4807 Fax: 843-876-4809 | |
Jennifer Lee Martin, D.O. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Nikko Rowe Asuncion Tabliago, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2575 | |
Moses K Asempah, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 717-491-3745 | |
Paige Nicole Laverick, PA-C Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Amit Agrawal, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Yevgeniy Gelfand, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-0111 |